Nuvectis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	119	145	110
Market Cap Growth	-24.66%	31.58%	-
Enterprise Value	100	125	90
PE Ratio	-	-6.49	-5.75
PB Ratio	8.52	11.84	7.72
P/FCF Ratio	-9.38	-9.06	-8.10
P/OCF Ratio	-9.38	-9.06	-8.10
EV/EBITDA Ratio	-5.64	-5.63	-4.71
EV/EBIT Ratio	-5.64	-5.63	-4.71
EV/FCF Ratio	-8.13	-7.86	-6.62
Quick Ratio	3.42	2.74	3.23
Current Ratio	3.46	2.75	3.30
Return on Equity (ROE)	-141.60%	-144.80%	-125.90%
Return on Assets (ROA)	-104.00%	-107.80%	-99.00%
Return on Capital (ROIC)	-165.40%	-187.66%	-135.27%
Earnings Yield	-18.73%	-15.40%	-17.38%
FCF Yield	-13.00%	-11.04%	-12.35%
Buyback Yield / Dilution	-12.46%	-22.90%	-196.55%
Total Shareholder Return	-12.46%	-22.90%	-196.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).